
Enzyme Modulators
Subcategories of "Enzyme Modulators"
Found 693 products of "Enzyme Modulators"
RNase A (8-13)
H-FERQHM-OH peptide, corresponding to RNase A 8-13 (Chain A of bovine pancreatic ribonuclease) is a non-amyloidogenic peptide, that can be used as a negative control in amyloid formation experiments together with CRB1001320.
Purity:Min. 95%Molecular weight:846.4 g/molAbltide
Abltide represents the optimal substrate peptide of Abl (or c-Abl), a non-receptor tyrosine kinase (NRTK) and the oncogenic Bcr-Abl tyrosine kinase (TK) (formed via a fusion between the Abelson (Abl) TK gene and the break point cluster region protein Brc). Abl was discovered as the gene from which the Abelson leukaemia virus derived its Gag-v-Abl oncogene.TKs are critical enzymes involved in multiple signalling pathways. However, Tks can promote cancer progression when deregulated, for example deregulated TK, Bcr-Abl gives rise to chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphocytic leukaemia (Ph+ ALL).Abl is activated by various signals including: growth factors, cytokines, cell adhesion, DNA damage and oxidative stress and results in the stimulation of both pro- and anti-apoptotic roles, cell proliferation or differentiation, retraction, or migration. Abl phosphorylates a large number of functionally diverse substrates, in part due to its ability to shuttle between the cytosol and the nucleus and bind both DNA and actin&mdash-two biopolymers with fundamental roles in almost all biological processes.Purity:Min. 95%Color and Shape:PowderMolecular weight:1,263.7 g/molPep2-8
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is negative regulator of hepatic low-density lipoprotein (LDL) receptors by promoting their degradation. This leads to an increase in plasma levels of cholesterol-LDL (LDL-c). PCSK9 binds to the LDL receptor at the epidermal growth factor precursor homology domain A (EGF-A) which leads the receptor to be targeted for degradation. Natural loss of function mutations in PCSK9 have been linked to improved coronary health and lower cholesterol levels with reduced risk of coronary heart disease. This has led to further study to find inhibitors of PCSK9 with the hope that they may be clinically relevant in the future.As discussed, PCSK9 binds to EGF-A on the LDL receptor. A peptide named pep 2-8 is a mimic of EGF-A and binds PCSK9 in the same manner observed with the LDL receptor. Pep 2-8 is a potent selective competitive inhibitor of PCSK9. Pep 2-8 restores LDL receptor function and LDL uptake of PCSK9-treated HepG2 cells. This is still an active area of research to optimise inhibition of PCSK9 for cholesterol regulation.Pep 2-8 has also been utilised as an anchor peptide in phage-display experiments to bind an extension peptide library to the groove site.Peptide Ac-TVFTSWEEYLDWV-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice.
Purity:Min. 95%Molecular weight:1,714.8 g/molBrigatinib
CAS:Pan-ALK receptor tyrosine kinase inhibitorFormula:C29H39ClN7O2PPurity:Min. 98 Area-%Color and Shape:White PowderMolecular weight:584.09 g/molImidapril hydrochloride
CAS:Angiotensin-converting enzyme inhibitorFormula:C20H27N3O6•HClPurity:Min. 95%Color and Shape:White To Off-White SolidMolecular weight:441.91 g/molNilotinib - Bio-X ™
CAS:Nilotinib is tyrosine kinase inhibitor drug that is used to treat chronic myeloid leukemia (CML). It inhibits the activity of the BCR-ABL protein kinase, which is involved in the development of CML. Additionally, it inhibits PDGF and c-kit for the potential treatment of various leukemias.Formula:C28H22F3N7OPurity:Min. 95%Color and Shape:PowderMolecular weight:529.52 g/molFlavoxate HCl - Bio-X ™
CAS:Flavoxate is a muscarinic antagonist and spasmolytic drug that is used for the relief of conditions associatied with a lack of muscle control in the bladder such as urine urgency. This drug acts as a direct antagonist on acetylcholine receptors. This action reduces the tonus of smooth muscles in the bladder.Formula:C24H25NO4•HClPurity:Min. 95%Color and Shape:PowderMolecular weight:427.92 g/molTemocapril hydrochloride
CAS:Angiotensin-converting enzyme inhibitor; anti-hypertensiveFormula:C23H29ClN2O5S2Purity:Min. 95%Color and Shape:SolidMolecular weight:513.07 g/molSB 61211 hydrochloride
CAS:Nociceptin/orphanin FQ peptide receptor antagonistFormula:C24H29Cl2NO·HClPurity:Min. 95%Molecular weight:454.86 g/molNeostigmine bromide
CAS:Inhibitor of acetylcholinesterase
Formula:C12H19BrN2O2Purity:Min. 95%Molecular weight:303.2 g/molBosutinib
CAS:Inhibitor of Abl and Src kinases; anti-proliferative; antineoplasticÂFormula:C26H29Cl2N5O3Purity:Min. 95%Color and Shape:Off-White PowderMolecular weight:530.45 g/molAlectinib hydrochloride
CAS:An active product of vitamin A metabolism. Activates RXR and RAR receptor isoforms with high binding affinity. Induces differentiation of neural stem cells into neurons.Formula:C30H34N4O2·HClPurity:Min. 95%Color and Shape:Off-White To Beige SolidMolecular weight:519.08 g/molCAL 130 hydrochloride
CAS:PI3K enzyme inhibitorFormula:C23H22N8OPurity:Min. 95%Molecular weight:426.19166BRL 50481
CAS:Inhibitor of phosphodiesterase 7Formula:C9H12N2O4SPurity:Min. 95%Color and Shape:PowderMolecular weight:244.05178Tolrestat
CAS:Aldose reductase AKR1B10 inhibitor; hepatotoxic
Formula:C16H14F3NO3SPurity:Min. 95%Molecular weight:357.35 g/molRaltitrexed
CAS:Anti-folate inhibitor of thymidylate synthaseFormula:C21H22N4O6SPurity:Min. 95%Color and Shape:SolidMolecular weight:458.49 g/molCyclosporin B
CAS:Cyclosporin B is an antifungal and immunosuppressive cyclic peptide, which is derived from the fungus *Tolypocladium inflatum*. The compound is a member of the cyclosporin family, characterized by cyclic polypeptides with a unique arrangement of amino acids that enable its biological activity. Though its precise mode of action is not completely delineated, it is observed to influence cell growth and viability by potentially disrupting cellular communication or signal transduction pathways.
Formula:C61H109N11O12Purity:Min. 95%Color and Shape:PowderMolecular weight:1,188.59 g/molFlavopiridol
CAS:Inhibitor of CKD1, CDK2, and CDK4 serine/threonine kinasesFormula:C21H20ClNO5Purity:Min. 95%Color and Shape:Light (Or Pale) Yellow To Yellow SolidMolecular weight:401.103Rubitecan
CAS:Topoisomerase I inhibitorFormula:C20H15N3O6Purity:Min. 95%Molecular weight:393.35 g/molBML 257
CAS:Inhibits Akt translocation by targeting the pleckstrin homology (PH) domain. Inhibits hepatitis C virus NS5B RNA-dependent RNA polymerase (IC50 = 79 µM). Attenuates cannabinoid agonist-mediated proliferation of neural stem/precursor cells.Formula:C21H14N2O2Purity:Min. 95%Color and Shape:PowderMolecular weight:326.35 g/mol
